[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337885-105":59,"doc-detail-337885-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","in-silico-analysis-unveiling-potential-biomarkers-in-gallbladder-carcinogenesis","In silico analysis unveiling potential biomarkers in gallbladder carcinogenesis","","Gallbladder cancer (GBC) is an aggressive digestive tract malignancy with high mortality, largely because it is frequently asymptomatic and diagnosed at advanced stages. Conventional treatment options are limited, and the lack of specific early diagnostic and prognostic molecular markers remains a major barrier. Using network-centric in silico analysis of two microarray datasets (GSE202479 and GSE13222), the study identifies 50 differentially expressed genes and highlights 12 highly interconnected hub genes. Survival analysis supports TRIP13, NEK2, and TPX2 as prognostic candidates.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/in-silico-analysis-unveiling-potential-biomarkers-in-gallbladder-carcinogenesis/337885/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/in-silico-analysis-unveiling-potential-biomarkers-in-gallbladder-carcinogenesis/337885.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is early diagnosis of gallbladder cancer difficult?","Question",{"text":113,"@type":114},"GBC is often asymptomatic and commonly detected at an advanced, aggressive stage, making early detection unlikely. The lack of specific early diagnostic and prognostic molecular markers further limits progress.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What datasets and method were used to identify biomarkers?",{"text":118,"@type":114},"The study used two microarray datasets (GSE202479 and GSE13222) from the GEO database. A network-centric in silico analysis was performed to screen differentially expressed genes and identify interconnected hub genes.",{"name":120,"@type":111,"acceptedAnswer":121},"Which genes were proposed as candidate biomarkers and why?",{"text":122,"@type":114},"TRIP13, NEK2, and TPX2 were selected because they show strong network interactions and are supported by survival analysis. Their association with higher mortality suggests biomarker potential for diagnosis and prognosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337885,1790307117,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIn silico analysis unveiling potential biomarkers in gallbladder carcinogenesis  \nRaviranjan Kumar Gupta1, Ravi Bhushan2, Saket Kumar 3 & Shyam Babu Prasad1*  \nGallbladder cancer (GBC) is a rare but very aggressive most common digestive tract cancer with a high mortality rate due to delayed diagnosis atthe advanced stage. Moreover, GBC progression shows asymptomatic characteristics making it impossible to detect at an early stage. In these circumstances, conventional therapy like surgery, chemotherapy, and radiotherapy becomes refractive. However, few studies reported some molecular markers like KRAS (Kirsten Rat Sarcoma) mutation, upregulation of HER2/neu, EGFR (Epidermal Growth Factor Receptor), and microRNAs inGBC. However, the absence of some specific early diagnostic and prognostic markers is the biggest hurdle for the therapy of GBC to date. The present study has been designed to identify some specific molecular markers for precise diagnosis, and prognosis, for successful treatment of the GBC. By In Silico a network-centric analysis of two microarray datasets; (GSE202479) and (GSE13222) from the Gene Expression Omnibus (GEO) database, shows 50 differentially expressed genes (DEGs) associated with GBC. Further network analysis revealed that 12 genes are highly interconnected based on the highest MCODE (Molecular Complex Detection) value, among all three genes; TRIP13 (Thyroid Receptor Interacting Protein), NEK2 (Never in Mitosis gene-A related Kinase 2), and TPX2 (Targeting Protein for Xklp2) having highest network interaction with transcription factors and miRNA suggesting critically associated with GBC. Further survival analysis data corroborate the association of these genes; TRIP13, NEK2, and TPX2 with GBC. Thus, TRIP13, NEK2, and TPX2 genes are significantly correlated with a greater risk of mortality, transforming them from mere biomarkers of the GBC for early detections and may emerge as prognostic markers for treatment.  \nKeywords Gallbladder cancer (GBC), Biomarkers, Network analysis, TRIP13, NEK2, TPX2, Prognosis, Diagnosis, Treatment, Therapeutic targets  \nGallbladder cancer (GBC) is a rare and highly fatal type malignancy, that represents almost 50% of all digestive tract cancer1. It is the fifth most common digestive tract cancer worldwide and has a specific geographic distribution with some ethnic variation1. GBC is most prevalent in the northern Indian population in the World living near the rural Gangetic basin, and recording about 1.7% of cancer-related mortality and 220,000 incidence cases in 20181,2. The major etiological factors of GBC include Chronic inflammation and, a history of gallstones (cholelithiasis), and the risk increases with gallstone size, chronicity, and burden of symptoms2. GBC is often asymptomatic, detected at the advanced stage when it becomes very aggressive leading to poor prognosis2,3. The delay in detection often limits the effectiveness of treatment options. Moreover, the absence of specific molecular markers for early diagnosis and to development of prognostic markers is a major hurdle to managing this disease burden. This has prompted a growing interest in the role of biomarkers as indispensable tools in the battle against gallbladder cancer4. The identification of biomarkers, in this context, encompasses a diverse range of molecular, genetic, or biochemical indicators that can be objectively measured in biological samples5. Recent advancementsin genomic and proteomic technologies could help in the identification of several promising biomarkers associated with gallbladder cancer6. By providing valuable insights into the underlying molecular mechanisms and disease progression, they empower clinicians to make informed decisions tailored to each patient’s unique profile7.  \nDespite the advancement in transcriptomics and microarray bioinformatics, still there is a very scarce study that shows the poten","cbCairX1fvmM7bRA","https://ap.wps.com/l/cbCairX1fvmM7bRA","pdf",2092491,"English","# Background and rationale\n## Study aim and datasets\n## Differential expression and network analysis\n## Candidate biomarker selection and survival validation\n## Clinical significance","[{\"question\":\"Why is early diagnosis of gallbladder cancer difficult?\",\"answer\":\"GBC is often asymptomatic and commonly detected at an advanced, aggressive stage, making early detection unlikely. The lack of specific early diagnostic and prognostic molecular markers further limits progress.\"},{\"question\":\"What datasets and method were used to identify biomarkers?\",\"answer\":\"The study used two microarray datasets (GSE202479 and GSE13222) from the GEO database. A network-centric in silico analysis was performed to screen differentially expressed genes and identify interconnected hub genes.\"},{\"question\":\"Which genes were proposed as candidate biomarkers and why?\",\"answer\":\"TRIP13, NEK2, and TPX2 were selected because they show strong network interactions and are supported by survival analysis. Their association with higher mortality suggests biomarker potential for diagnosis and prognosis.\"}]","In silico analysis unveiling potential biomarkers in gallbladder carcinogenesis | PDF",1790021046,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b94fc0bbbea9a037235e86fd29f191b.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76a2ab733d4978fc9e22bb0a2ed711e7.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4288058e6f02d53b944d11a7d87fc75.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8644f727d859e5641023fdb7daa3103d.webp",980,1287]